These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30987181)

  • 1. IMM-H004 Protects against Cerebral Ischemia Injury and Cardiopulmonary Complications via CKLF1 Mediated Inflammation Pathway in Adult and Aged Rats.
    Ai Q; Chen C; Chu S; Luo Y; Zhang Z; Zhang S; Yang P; Gao Y; Zhang X; Chen N
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMM-H004 therapy for permanent focal ischemic cerebral injury via CKLF1/CCR4-mediated NLRP3 inflammasome activation.
    Ai QD; Chen C; Chu S; Zhang Z; Luo Y; Guan F; Lin M; Liu D; Wang S; Chen N
    Transl Res; 2019 Oct; 212():36-53. PubMed ID: 31176667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMM-H004 protects against oxygen-glucose deprivation/reperfusion injury to BV2 microglia partly by modulating CKLF1 involved in microglia polarization.
    Chen C; Ai Q; Chu S; Zhang Z; Zhou X; Luo P; Liu Y; Chen N
    Int Immunopharmacol; 2019 May; 70():69-79. PubMed ID: 30785093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound IMM-H004, a novel coumarin derivative, protects against CA1 cell loss and spatial learning impairments resulting from transient global ischemia.
    Zuo W; Zhang W; Han N; Chen NH
    CNS Neurosci Ther; 2015 Mar; 21(3):280-8. PubMed ID: 25601434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
    Zuo W; Chen J; Zhang S; Tang J; Liu H; Zhang D; Chen N
    Eur J Neurosci; 2014 Jun; 39(12):2107-18. PubMed ID: 24649933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMM-H004, A New Coumarin Derivative, Improved Focal Cerebral Ischemia via Blood-Brain Barrier Protection in Rats.
    Niu F; Song XY; Hu JF; Zuo W; Kong LL; Wang XF; Han N; Chen NH
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2065-2073. PubMed ID: 28669655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulating the Expression of Survivin-HBXIP Complex Contributes to the Protective Role of IMM-H004 in Transient Global Cerebral Ischemia/Reperfusion.
    Chu SF; Zhang Z; Zhang W; Zhang MJ; Gao Y; Han N; Zuo W; Huang HY; Chen NH
    Mol Neurobiol; 2017 Jan; 54(1):524-540. PubMed ID: 26742528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of chemokine-like factor 1, a novel C-C chemokine, protects against focal cerebral ischemia by inhibiting neutrophil infiltration via MAPK pathways in rats.
    Kong LL; Wang ZY; Han N; Zhuang XM; Wang ZZ; Li H; Chen NH
    J Neuroinflammation; 2014 Jun; 11():112. PubMed ID: 24946684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMM-H004, a Novel Coumarin Derivative Compound, Inhibits H
    Song XY; Hu JF; Wu DH; Ji HJ; Chen NH
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3396-3403. PubMed ID: 30243729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of chemokine-like factor 1 improves blood-brain barrier dysfunction in rats following focal cerebral ischemia.
    Kong LL; Wang ZY; Hu JF; Yuan YH; Li H; Chen NH
    Neurosci Lett; 2016 Aug; 627():192-8. PubMed ID: 27283776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IMM-H004, a novel courmarin derivative, protects against oxygen-and glucose-deprivation/restoration-induced apoptosis in PC12 cells.
    Ji HJ; Wang DM; Hu JF; Sun MN; Li G; Li ZP; Wu DH; Liu G; Chen NH
    Eur J Pharmacol; 2014 Jan; 723():259-66. PubMed ID: 24291097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new coumarin derivative, IMM-H004, attenuates okadaic acid-induced spatial memory impairment in rats.
    Song XY; Wang YY; Chu SF; Hu JF; Yang PF; Zuo W; Song LK; Zhang S; Chen NH
    Acta Pharmacol Sin; 2016 Apr; 37(4):444-52. PubMed ID: 26838073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rg1 treats ischemic stroke by regulating CKLF1/CCR5 axis-induced neuronal cell pyroptosis.
    Long J; Sun Y; Liu S; Chen C; Yan Q; Lin Y; Zhang Z; Chu S; Yang Y; Yang S; Lin M; Liu X; Liang J; Chen N; Ai Q
    Phytomedicine; 2024 Jan; 123():155238. PubMed ID: 38128394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IMM-H004, a novel coumarin derivative compound, protects against amyloid beta-induced neurotoxicity through a mitochondrial-dependent pathway.
    Song XY; Hu JF; Sun MN; Li ZP; Wu DH; Ji HJ; Yuan YH; Zhu ZX; Han N; Liu G; Chen NH
    Neuroscience; 2013 Jul; 242():28-38. PubMed ID: 23523945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of chemokine-like factor 1 protects against focal cerebral ischemia through the promotion of energy metabolism and anti-apoptotic effect.
    Kong LL; Wang ZY; Hu JF; Yuan YH; Han N; Li H; Chen NH
    Neurochem Int; 2014 Oct; 76():91-8. PubMed ID: 25042180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of chemokine-like factor 1 after focal cerebral ischemia in the rat.
    Kong LL; Hu JF; Zhang W; Yuan YH; Ma KL; Han N; Chen NH
    Neurosci Lett; 2011 Nov; 505(1):14-8. PubMed ID: 21964493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CKLF1 Aggravates Focal Cerebral Ischemia Injury at Early Stage Partly by Modulating Microglia/Macrophage Toward M1 Polarization Through CCR4.
    Chen C; Chu SF; Ai QD; Zhang Z; Guan FF; Wang SS; Dong YX; Zhu J; Jian WX; Chen NH
    Cell Mol Neurobiol; 2019 Jul; 39(5):651-669. PubMed ID: 30982091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of CKLF1 ameliorates hepatic ischemia-reperfusion injury via MAPK pathway.
    Li FF; Zhou X; Chu SF; Chen NH
    Cytokine; 2021 May; 141():155429. PubMed ID: 33578361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of IMM-H004 and its active glucuronide metabolite in rat plasma and Ringer's solution by ultra-performance liquid chromatography-tandem mass spectrometry.
    Jiang J; Zhang Z; Zou X; Wang R; Bai J; Zhao S; Fan X; Sheng L; Li Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1074-1075():16-24. PubMed ID: 29329091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux.
    Chen C; Ai QD; Wei YH
    J Ethnopharmacol; 2021 Jan; 264():113388. PubMed ID: 32918990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.